Articles by Daniel J. Herold, MD
A 64-Year-Old Man With Germline BRCA2-Mutated Breast Cancer: Known and Unknown Aspects of Male Breast Cancer
ByMehmet Sitki Copur, MD, FACP,Jacqueline R. Kelly, MD, MSc,Nicholas Lintel, MD,Bronson Riley, MS,Daniel J. Herold, MD,Shellie Faris, MD,Whitney Wedel, MD,Adam J. Horn, MD This study presents a male breast cancer case with a germline BRCA2 mutation and discusses the epidemiologic, pathologic, and clinical characteristics along with treatment and follow-up recommendations in view of our recent understanding of the disease.
Mucinous Adenocarcinoma of the Appendix With Histologic Response to Neoadjuvant Chemotherapy: Review of Histologic and Clinical Spectrum of Epithelial Neoplastic Mucinous Lesions of the Appendix
ByMehmet Sitki Copur, MD,Allison M. Cushman-Vokoun, MD, PhD,James Padussis, MD,Whitney Wedel, MD,Caleb W. Schroeder, MD,Daniel J. Herold, MD,Nicholas Lintel, MD,Adam J. Horn, MD Mehmet Sitki Copur, MD, and colleagues examine the case of a 65-year-old patient with appendiceal mucinous neoplasms of the appendix who was treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
